Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-content CRISPR screening in tumor immunology. | Front Immunol | 2022 | 36479127 | PubTator, text mining | PubMed |
| Secondary Acute Myeloid Leukemia in a Chronic Myeloid Leukemia Patient in Deep Molecular Response-An Unusual Case Report. | South Asian J Cancer | 2022 | 36466981 | PubTator, text mining | PubMed |
| Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report. | Front Immunol | 2022 | 36466893 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient. | Front Immunol | 2022 | 36466840 | PubTator, text mining | PubMed |
| Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature. | Front Oncol | 2022 | 36465368 | PubTator, text mining | PubMed |
| The kinase occupancy of T cell coreceptors reconsidered. | Proc Natl Acad Sci U S A | 2022 | 36454761 | PubTator, text mining | PubMed |
| Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. | Haematologica | 2022 | 36453516 | PubTator, text mining | PubMed |
| Analysis of herpesvirus infection and genome single nucleotide polymorphism risk factors in multiple sclerosis, Volga federal district, Russia. | Front Immunol | 2022 | 36451826 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. | Genome Med | 2022 | 36443794 | PubTator, text mining | PubMed |
| Nucleic acid vaccination strategies for ovarian cancer. | Front Bioeng Biotechnol | 2022 | 36420446 | PubTator, text mining | PubMed |
| Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers. | Comput Struct Biotechnol J | 2022 | 36420145 | PubTator, text mining | PubMed |
| Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics. | J Transl Med | 2022 | 36401282 | PubTator, text mining | PubMed |
| Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity. | Nat Commun | 2022 | 36396644 | PubTator, text mining | PubMed |
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. | Hum Vaccin Immunother | 2022 | 36369829 | PubTator, text mining | PubMed |
| Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. | Cancers (Basel) | 2022 | 36358863 | PubTator, text mining | PubMed |
| Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy. | Pharmaceuticals (Basel) | 2022 | 36355531 | PubTator, text mining | PubMed |
| Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress. | Front Immunol | 2022 | 36353616 | PubTator, text mining | PubMed |
| Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. | NPJ Breast Cancer | 2022 | 36351947 | PubTator, text mining | PubMed |
| Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations. | Front Immunol | 2022 | 36325357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=24